期刊文献+

回顾性治疗结局研究设计及其在中医学领域的应用展望 被引量:1

Design of Retrospective Treatment Outcome Research and Its Application in Traditional Chinese Medicine
原文传递
导出
摘要 回顾性治疗结局(RTO)研究是一种通过回顾性问卷调查或访谈,对已经出现临床结局的某一特定人群在某一特定时期的暴露因素或接受的治疗措施进行资料收集,分析各暴露因素或治疗措施与疾病结局之间相关性的观察性研究。其可用于初步评估治疗措施对特定人群已出现的疾病结局的有效性和安全性,识别与疾病结局关联较强的治疗措施,从而为后续的前瞻性临床试验提供线索。系统介绍RTO的概念、起源与方法学设计要点,对比RTO与其他观察性研究的异同,分析RTO的应用现状与展望、优势与局限性。在此基础上提出,在中医药领域可采用RTO研究筛选治疗某疾病的不同组方/配伍比例/剂量/剂型/给药方式的中药,初步评价中医特色疗法治未病的效果,遴选新发突发传染病的不同治疗方案等,以期为RTO研究在中医药领域的应用提供方法学参考。 Retrospective treatment outcome(RTO)is a kind of observational study that retrospectively collects data about the exposure factors or the interventions over a period of time in certain people who have already had clinical outcomes through questionnaire survey or interview,and analyzes the correlation between exposure factors or interventions and disease outcomes.RTO can initially evaluate the effectiveness and safety of the interventions for the specific group of people,and identify the treatments with the highest association with disease outcomes,thereby providing clues and evidence for subsequent prospective clinical trials.This study systematically introduced the concept,origin and methodological items of RTO,compared the similarities and differences between RTO and other observational studies,described the application status and prospects,advantages and limitations of RTO.It is proposed that future applications of RTO in traditional Chinese medicine(TCM)include such as screening out the Chinese material medica with different prescriptions/compatibility/dosage/preparations/modes of administration,evaluating the effect of TCM-specific therapies when treating disease before it arises,selecting the varied treatment options for emergent and novel infectious diseases.All these provide methodological references for the application of RTO in conducting TCM researches.
作者 蔡祎晴 金信妍 刘建平 CAI Yiqing;JIN Xinyan;LIU Jianping(Center for Evidence-Based Medicine,Beijing University of Chinese Medicine,Beijing,100029)
出处 《中医杂志》 CSCD 北大核心 2023年第8期799-804,共6页 Journal of Traditional Chinese Medicine
基金 厦门市科学技术局一般科技计划(应急攻关项目)(3502Z2021YJ12) 国家自然科学基金(81830115)。
关键词 回顾性治疗结局 问卷调查 观察性研究 真实世界研究 retrospective treatment outcome questionnaire survey observational study real-world study
  • 相关文献

参考文献6

二级参考文献47

  • 1于维洋,姜克.基于模糊理论的财务风险排序模型[J].北京市财贸管理干部学院学报,2005,21(3):43-46. 被引量:1
  • 2陈杰,徐红.抽样调查中样本量的设计和计算[J].武汉职业技术学院学报,2006,5(1):118-120. 被引量:29
  • 3卜全民,王涌涛,汪德爟.事故树分析法的应用研究[J].西南石油大学学报(自然科学版),2007,29(4):141-144. 被引量:99
  • 4流行病学.附录五:分析流行病学有关计算.[EB/oL].[2007-03-07].http://www.51daifu.com/medical_books/2007/0307/216BD73EA7C2DC0CH124920.shtml.
  • 5Dupont WD,Plummer WD.Power and sample size calculations:a review and computer program.Control Clin Trials,1990,11(2):116-128.
  • 6Gauderman WJ.Sample size requirements for matched case-control studies of gene-environment interaction.Stat Med,2002,21(1):35-50.
  • 7张玮炜,尹志军,陈立文.基于全生命周期的项目风险分析方法比较研究[J].科技管理研究,2007,27(9):104-106. 被引量:18
  • 8KU WW,BIGGER A,BRAMBILLA G,et al. Strategy for geno-toxicity testing-Metabolic considerations [ J ]. Mutat Res,2007 ,627(1) : 59 -77.
  • 9BRAMBILLA G,MARTELLI A. Failure of the standard batteryof short-term tests in detecting some rodent and human genotoxiccarcinogens [ J]. Toxicology, 2004, 196 (1 -2): 1 -19.
  • 10TWEATS DJ, BLAKEY D, HEFLICH RH. Report of the IWGTworking group on strategy/interpretation for regulatory in vivo testsII . Identification of in vivo-only positive compounds in the bonemarrow micronucleus test[ J]. Mutat Res, 2007,627 (1) : 92 -105.

共引文献187

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部